POAG detection successful with tract-based spatial imaging

Article

Tract-based spatial statistical analysis of diffusion tensor imaging is a successful tool for the detection of cortical nerve fibre loss in primary open-angle glaucoma (POAG) patients, claims a recent paper.

Tract-based spatial statistical analysis of diffusion tensor imaging is a successful tool for the detection of cortical nerve fibre loss in primary open-angle glaucoma (POAG) patients, claims a recent paper.

Dr Zhiqi Chen et al., Department of Ophthalmology, Tongji Hospital, Shanghai City, China, devised a cross-sectional investigation consisting of 25 patients with POAG and 24 healthy control subjects.

All participants underwent thorough ophthalmological assessments, including cup-to-disc ratio, retinal nerve fibre layer thickness and a visual field test. The main outcome measures were diffusivity changes of the nerve fibres in the visual pathway, mean diffusivity and fractional anisotrophy. All measurements were compared with ophthalmological data.

Bilateral optic tracts and optic radiations in POAG patients demonstrated significantly decreased fractional anisotrophy and increased mean diffusivity, compared to the control group.

The fractional anisotrophy of the optic tracts and optic radiations consistently varied with cup-to-disc ratio, retinal nerve fibre layer thickness and visual function analysis, respectively.

There was no significant correlation between the mean diffusivity of the optic radiations and the ophthalmological measurements. But the mean diffusivity of the optic tracts correlated with the ophthalmological measurements.

Optic tracts and optic radiations of POAG patients revealed radiological evidence of neurodegeneration, which varied with optic disc damage and loss of visual function.

The abstract can be found in the journal Clinical and Experimental Ophthalmology.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.